The veterinary point of care diagnostics market has seen considerable growth due to a variety of factors.
• Recent years have seen a quick expansion in the market size of veterinary point of care diagnostics. Predictabilities suggest an increase from $1.78 billion in 2024 to $2.01 billion in 2025, yielding a compound annual growth rate (CAGR) of 12.9%. The escalation witnessed in the past can be attributed to numerous factors including educational and awareness programs, integration with telemedicine, a concentrated effort on infectious disease control, regulatory support and approvals, along with livestock and production animal management.
The Veterinary Point Of Care Diagnostics market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for veterinary point of care diagnostics is predicted to experience significant expansion in the coming years, with expectations to reach $3.33 billion in 2029 at a compound annual growth rate (CAGR) of 13.5%.
Factors contributing to this growth during the forecasted period include the rise in pet ownership, a focus on preventive health care, the need for remote and rural access, personalized animal treatment, and global health readiness. The forecasted period also foresees trends such as technological progressions, innovative products, and a consumer shift towards at-home testing.
The growth of the veterinary point-of-care diagnostics market is being spurred on by a rising population of companion animals. These are pets that live in the same residential spaces as humans. This growth in companion animal numbers is leading to more demand for veterinary point-of-care diagnostics, which enables swift decision making in regards to diagnosis, choice of treatment, monitoring, prognosis, and operation, as well as utilisation of resources. As an example, data from the 2021-2022 National Pet Owners Survey by the American Pet Products Association, a non-profit industry group based in the US, shows that companion animals are found in 70% of all US households. Hence, the escalating companion animal population is fuelling the growth of the veterinary point-of-care diagnostics market.
The veterinary point of care diagnostics market covered in this report is segmented –
1) By Product: Consumables, Reagents And Kits, Instruments And Devices
2) By Animal Type: Companion Animals, Livestock Animals
3) By Disease: Infectious Diseases, Metabolic Diseases, Other Diseases
4) By Technology: Immunodiagnostics, Clinical Biochemistry, Molecular Diagnostics, Hematology, Urinalysis, Other Technologies
5) By End User: Veterinary Clinics, Veterinary Hospitals And Academic Institutes, Home Care Settings
Subsegments:
1) By Consumables: Test Strips, Blood Collection Tubes, Urine Test Strips, Microbial Culture Media
2) By Reagents And Kits: Enzyme-Linked Immunosorbent Assay (ELISA) Kits, PCR Reagents, Rapid Test Kits, Diagnostic Assay Kits
3) By Instruments And Devices: Portable Analyzers, Diagnostic Imaging Devices, Hematology Analyzers, Biochemical Analyzers
Key players within the veterinary point-of-care diagnostics market are focusing on the creation of new veterinary analyzers in order to maintain their market positioning. For example, Chengdu Seamaty Technology Co., Ltd., a Chinese firm specializing in the production of medical equipment, unveiled four cutting-edge veterinary analyzers in August 2023. These were primarily intended for use in pet hospitals, underlining the essential nature of on-site diagnostics. The novel devices, namely the VG2 Vet Blood Gas Electrolyte Immunoassay Analyzer, VG1 Veterinary Blood Gas & Electrolyte Analyzer, Vi1 Veterinary Fluorescence Immunoassay Analyzer, and the VBC30/VBC50 Hematology Analyzers, offer fast and accurate diagnostic insights into diseases, immune responses, and inflammation monitoring in dogs and cats. Their user-friendly interfaces and portability make them easily incorporable into veterinary procedures, thus increasing efficiency and aiding in the swift decision-making process for the best patient care.
Major companies operating in the veterinary point of care diagnostics market include:
• Zoetis Inc.
• IDEXX Laboratories Inc.
• Heska Corporation
• Virbac Animal Health India Pvt Ltd
• Eurolyser Diagnostica GmbH
• Randox Laboratories Ltd
• Anipoc Ltd
• Neogen Corporation
• Abaxis Inc.
• Alvedia
• bioMérieux SA
• Bionote Inc.
• Clindiag Systems Co. Ltd.
• Coris BioConcept
• Creative Diagnostics
• DiaSys Diagnostic Systems GmbH
• Eiken Chemical Co. Ltd.
• Gold Standard Diagnostics Corp.
• Hangzhou AllTest Biotech Co. Ltd.
• InBios International Inc.
North America was the largest region in the veterinary point of care diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary point of care diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.